High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report
Article in Translational Lung Cancer Research (January 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer
Article in Communications Biology (November 2021)
Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib
Article in Thoracic Cancer (April 2019)